RESUMEN
INTRODUCTION: Atopic dermatitis (AD) is a chronic, inflammatory skin disorder with eczematous and pruritic lesions. Topical moisturisers and either topical corticosteroids or calcineurin inhibitors are usually recommended. Restoring the skin barrier function alleviates AD symptoms. OBJECTIVE: To evaluate the efficacy of a new moisturiser compared to commercially available products in an AD murine model. METHODS: Experimental AD was induced with topical applications of 2,4-DiNitroChloroBenzene (DNCB) on the shaved back skin of BALB/c mice from Day 1 to Day 38. Mice were randomized to either Vehicle/-, DNCB/-, or DNCB/Eczekalm (test product), DNCB/Atopiclair®, or DNCB/Lipikar (reference products) groups. Once daily application of either Eczekalm or Atopiclair® or Lipikar on the AD lesion was performed from Day 32 to Day 38. The AD severity index (ADSI) and animal behaviour were monitored throughout the study. The trans-epidermal water loss (TEWL) was measured on the sacrifice day (Day 39). RESULTS: At Day39, ADSI in the DNCB/Eczekalm, DNCB/Lipikar, and DNCB/Atopiclair® groups were significantly lower by -70%, -68%, and -57%, respectively, as compared to DNCB/- (p < 0.001). No sign of erythema was observed in the DNCB/Eczekalm group. Mean scores of skin oedema, excoriation, and dryness in the DNCB/Eczekalm, DNCB/Lipikar, and DNCB/Atopiclair® groups were significantly lower than in the DNCB/-. No significant difference was observed between DNCB/Eczekalm and DNCB/Lipikar groups. Mean TEWL in DNCB/Eczekalm group was significantly lower than the ones of DNCB/Atopiclair® (-43%, p < 0.001) and DNCB/Lipikar (-15%, p < 0.05). CONCLUSION: Eczekalm treatment significantly reduced the inflammatory effects due to AD and itching episodes and restored the skin barrier function.
Asunto(s)
Dermatitis Atópica , Ratones , Animales , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dinitroclorobenceno/efectos adversos , Ratones Endogámicos BALB C , Inmunoglobulina E , Piel , CitocinasRESUMEN
The optical properties of thin films are generally determined by direct photometric quantities. We show that additional insight into the properties of anisotropic thin films can be obtained by computing the polarization eigenstates and eigenvalues of their Jones matrices. We consider helically structured thin films, which display intriguing optical response, such as the circular Bragg resonance. Using numerical simulations and actual measurements, we show that the eigenvectors are mutually orthogonal in most regions of the wavevector space, except near the circular Bragg and the oblique resonances. Special wavevector values, called exceptional points, are found where the Jones matrix becomes defective and its eigenvectors coalesce. Exceptional points are also found in pairs of wavevector values differing only by a sample rotation by π around the direction normal to the sample; this property is shown to arise from Saxton - de Hoop's reciprocity principle, which applies to lossy materials and contains time reversal symmetry, which only applies to lossless materials, as a special case.
RESUMEN
Previous studies have found that use of hexaminolevulinate (HAL) and blue light cystoscopy (BLC) during treatment of bladder cancer had a positive impact on overall survival after later cystectomy, indicating a potential treatment effect beyond improved diagnostic accuracy. The aim of our study was to determine whether HAL and BL mimicking clinically relevant doses in an orthotopic rat model could have therapeutic effect by inducing modulation of a tumor-specific immune response. We also assessed whether administration with a checkpoint inhibitor could potentiate any effects observed. Rats were subjected to HAL BL alone and in combination with anti-PD-L1 and assessed for anti-tumor effects and effects on immune markers. Positive anti-tumor effect was observed in 63% and 31% of rats after, respectively, 12 and 30 days after the procedure, together with a localization effect of CD3+ and CD8+ cells after 30 days. Anti-tumor effect at 30 days increases from 31% up to 38% when combined with intravesical anti-PD-L1. In conclusion, our study demonstrated treatment effects with indications of systemic immune activation at diagnostic doses of HAL and blue light. The observed treatment effect seemed to be enhanced when used in combination with intravesically administrated immune checkpoint inhibitor.
RESUMEN
Exceptional points (EPs) in the polarization space were observed in reflection on helically structured thin films. These films have form anisotropy at the nanoscale introduced through dynamic control of crystalline growth geometry by changing the orientation of the substrate with respect to the impinging vapor. They are simpler alternatives to metasurfaces, because they can be produced at low cost using conventional thin-film deposition techniques. The EPs were experimentally confirmed by eigenstate swapping on a closed circuit surrounding them and were predicted by numerical calculations. Reflective surfaces operating at an EP could be used to make ultrasensitive sensors.
RESUMEN
Multimode laser emission generally takes place in homogeneously broadened gain media placed inside a standing-wave resonator due to spatial hole burning. Solutions proposed to eliminate this phenomenon have so far involved the use of intracavity elements, such as an etalon, wave plates or saturable absorbers. We propose a monolithic solution, wherein birefringent layers of TiO2 are deposited on both laser mirrors. This solution enables one to control the contrast of the interference pattern of the standing wave inside the resonator, and thus the strength of the spatial hole burning, by rotating one mirror around the optical axis. A monochromatic laser emission is demonstrated in a quasi-continuous-wave laser-diode-pumped Yb3+:YAG laser experiment.
RESUMEN
OBJECTIVES: The green seaweed Ulva sp. contains a large amount of ulvans, a family of sulphated polysaccharides. The present study was designed to investigate in rats the antidepressant- and anxiolytic-like effects of a hydrophilic extract of Ulva sp. (MSP) containing about 45% of ulvans. METHODS: After a 14-day administration of MSP at doses of 10, 20 and 40â mg/kg/day, 48 and 60 male adult Wistar rats were respectively tested in the elevated plus-maze (EPM) and the forced swimming test (FST). In the FST, MSP effects were compared to the reference antidepressant drug imipramine (IMI) (10â mg/kg/day). Acute and sub-chronic toxicities of the extract were also assessed in male and female rats following OECD guidelines. RESULTS: MSP treatment did not modify anxiety-related behaviour in the EPM. In contrast, MSP induced a dose-dependent reduction of immobility behaviour in the FST. At the highest tested dose of 40â mg/kg, MSP displayed a significant antidepressant-like effect similar to IMI. MSP did not modify the exploratory behaviour of rats in the open field test and did not produce any toxic effect. DISCUSSION: MSP may potentially represent a good adjunct or alternative to existing antidepressant therapeutics. Further studies are necessary to confirm the mechanism of action of MSP and its modulation of brain functioning.
Asunto(s)
Ansiolíticos/farmacología , Antidepresivos/farmacología , Extractos Vegetales/farmacología , Ulva/química , Animales , Ansiolíticos/administración & dosificación , Ansiolíticos/toxicidad , Antidepresivos/administración & dosificación , Antidepresivos/toxicidad , Conducta Animal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Conducta Exploratoria/efectos de los fármacos , Femenino , Imipramina/farmacología , Masculino , Extractos Vegetales/administración & dosificación , Extractos Vegetales/toxicidad , Ratas , Ratas Wistar , Natación , Pruebas de Toxicidad Aguda , Pruebas de Toxicidad SubcrónicaRESUMEN
A polarizing laser mirror was made of an alternating sequence of low and high refractive index layers of titanium oxide using glancing angle deposition (GLAD). Large refractive index contrast and large birefringence, reaching 0.5 and 0.1, respectively, could be obtained from one single raw material by changing the deposition conditions. The laser mirror could withstand a train of 2.7 ns, single-mode pulses at 680 Hz, λ=1030 nm, and peak power density of 670 MW/cm2 when used as an output coupler of a passively Q-switched (Yb0.1Y0.9)3Al5O12 ceramic laser. The polarization extinction ratio was found to be better than 30 dB both in continuous-wave and pulsed regimes. These results indicate that polarizing laser mirrors made from nanostructured thin films with GLAD, in addition to being simple to fabricate, can withstand high pulse energy density.
RESUMEN
Chlorella sp. is a green microalgae containing nutrients, vitamins, minerals, and chlorophyll. In some communities, Chlorella sp. is a traditional medicinal plant used for the management of inflammation-related diseases. In a rat model, ROQUETTE Chlorella sp. (RCs) benefits were investigated on visceral pain and associated inflammatory parameters related to cystitis both induced by cyclophosphamide (CYP). RCs was orally administered every day from day 1-16 (250 and 500 mg/kg body weight). Six hours after an intraperitoneal injection of 200 mg/kg body weight of CYP, body temperature, general behavior, food intake, and body weight were recorded. Twenty-four hours after CYP injection, rats were tested in two behavioral tests, an open field and the aversive light stimulus avoidance conditioning test, to evaluate the influence of pain on general activity and learning ability of rats. After euthanasia, bladders were weighed, their thickness was scored, and the urinary hemoglobin was measured. RCs orally administered at the two dosages significantly reduced visceral pain and associated inflammatory parameters related to cystitis both induced by CYP injection, and improved rat behavior. To conclude, RCs demonstrated beneficial effects against visceral pain and cystitis.
Asunto(s)
Factores Biológicos/administración & dosificación , Chlorella/química , Cistitis/tratamiento farmacológico , Dolor Visceral/tratamiento farmacológico , Animales , Peso Corporal/efectos de los fármacos , Ciclofosfamida/administración & dosificación , Ciclofosfamida/efectos adversos , Cistitis/inducido químicamente , Cistitis/fisiopatología , Modelos Animales de Enfermedad , Ingestión de Alimentos/efectos de los fármacos , Femenino , Humanos , Ratas , Ratas Wistar , Dolor Visceral/inducido químicamente , Dolor Visceral/fisiopatologíaRESUMEN
Fluorene is one of the most abundant polycyclic aromatic hydrocarbons (PAHs) in the environment by reason of its high volatility. Demonstrated to be a neurotoxicant through inhalation, it was also identified as a contributive PAH to food contamination. Since no data are available on its oral neurotoxicity, the purpose of the present study was to assess the behavioral and physiological toxicity of repeated oral administration of fluorene to adult Wistar male rats. Animals were daily treated with fluorene at 1, 10 or 100mg/kg/day for 28 consecutive days. Administration was intraperitoneal (i.p.) or oral (p.o.) to evaluate the influence of the route of exposure on fluorene toxicity. Following this period of treatment, animals in both groups were subjected to similar cognitive evaluations, namely anxiety (elevated-plus maze), locomotor activity (open-field) and learning and memory abilities (eight-arm maze and avoidance test of an aversive light stimulus), as well as physiological measurements. The behavioral testing occurred from the 28th to the 60th day of the experiment during which fluorene treatment continued uninterrupted. At the end of this period, the concentration levels of fluorene and of three of its monohydroxylated metabolites in blood and brain were determined using a GC-MS/MS method. The results demonstrated a reduction in rat anxiety level at the lowest doses administered (1 and 10mg/kg/day) regardless of the treatment route, whereas locomotor activity and learning abilities remained unchanged. Moreover, a less significant weight gain was noticed in animals i.p.- and p.o.-treated with 100mg/kg/day during the 28-day period of treatment, which, upon comparison with the three other groups, induced a body weight gap that was maintained throughout the experiment. Significant increases in relative liver weight were also observed in a dose-dependent manner in orally treated rats and only in animal treated i.p. with 100mg/kg/day. According to the dose, higher concentration levels of fluorene and its monohydroxylated metabolites were measured in blood and brain compartments of i.p.-treated rats compared to p.o.-treated animals. In conclusion, fluorene reduced the anxiety level of rats related to dose, treatment route, duration of exposure and blood concentration levels of metabolites.
Asunto(s)
Administración Oral , Ansiedad/inducido químicamente , Carcinógenos/administración & dosificación , Trastornos del Conocimiento/inducido químicamente , Fluorenos/administración & dosificación , Inyecciones Intraperitoneales , Análisis de Varianza , Animales , Reacción de Prevención/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Carcinógenos/metabolismo , Carcinógenos/toxicidad , Relación Dosis-Respuesta a Droga , Conducta Exploratoria/efectos de los fármacos , Fluorenos/metabolismo , Fluorenos/toxicidad , Luz/efectos adversos , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratas , Factores de TiempoRESUMEN
Treatment of stroke, especially during the first hours or days, is still lacking. S-nitrosoglutathione (GSNO), a cerebroprotective agent with short life time, may help if administered early with a sustain delivery while avoiding intensive reduction in blood pressure. We developed in situ forming implants (biocompatible biodegradable copolymer) and microparticles (same polymer and solvent emulsified with an external oily phase) of GSNO to lengthen its effects and allow cerebroprotection after a single subcutaneous administration to Wistar rats. Arterial pressure was recorded for 3 days (telemetry, n = 14), whole-blood platelet aggregation up to 13 days (aggregometry, n = 58), and neurological score, cerebral infarct size and edema volume for 2 days after obstruction of the middle cerebral artery by autologous blood clots (n = 30). GSNO-loaded formulations (30 mg/kg) induced a slighter and longer hypotension (-10 vs. -56 ± 6 mmHg mean arterial pressure, 18 h vs. 40 min) than free GSNO at the same dose. The change in pulse pressure (-50%) lasted even up to 42 h for microparticles. GSNO-loaded formulations (30 mg/kg) prevented the transient 24 h hyper-aggregability observed with free GSNO and 7.5 mg/kg-loaded formulations. When injected 2 h after stroke, GSNO-loaded microparticles (30 mg/kg) reduced neurological score at 24 (-62%) and 48 h (-75%) vs. empty microparticles and free GSNO 7.5 mg/kg and, compared to free GSNO, divided infarct size by 10 and edema volume by 8 at 48 h. Corresponding implants reduced infarct size and edema volume by 2.5 to 3 times. The longer (at least 2 days) but slight effects on arterial pressures show sustained delivery of GSNO-loaded formulations (30 mg/kg), which prevent transient platelet hyper-responsiveness and afford cerebroprotection against the consequences of stroke. In conclusion, in situ GSNO-loaded formulations are promising candidates for the treatment of stroke.
Asunto(s)
Fármacos Neuroprotectores/uso terapéutico , S-Nitrosoglutatión/uso terapéutico , Accidente Cerebrovascular/tratamiento farmacológico , Animales , Presión Sanguínea/efectos de los fármacos , Modelos Animales de Enfermedad , Inyecciones Subcutáneas , Masculino , Microesferas , Fármacos Neuroprotectores/administración & dosificación , Agregación Plaquetaria/efectos de los fármacos , Ratas , Ratas Wistar , S-Nitrosoglutatión/administración & dosificación , TelemetríaRESUMEN
A novel method is proposed for the fabrication of polarizing laser mirrors for compact solid-state lasers using glancing angle deposition. Changing the inclination angle and the azimuthal orientation of the substrate during deposition allows one to create and control in-plane birefringence of a deposited thin film by changing its nanostructure. Principal refractive indices of tungsten trioxide films were determined for various deposition angles using transmission and reflection ellipsometry. High-reflectance contrast between orthogonal linear polarization directions was obtained using a single material without any additional processing steps. These birefringent films were the building blocks of a Bragg mirror that was tested as an output coupler of a (Yb0.1Y0.9)3Al5O12 ceramic laser in a laser-diode end-pumped configuration. Continuous-wave, linearly polarized, transverse single-mode laser emission was obtained at a wavelength of 1030 nm with a polarization extinction ratio higher than 973 (30 dB).
RESUMEN
Inflammation adversely affects the health of millions of people worldwide, and there is an unmet medical need for better anti-inflammatory drugs. We evaluated the therapeutic interest of mycolactone, a polyketide-derived macrolide produced by Mycobacterium ulcerans. Bacterial production of mycolactone in human skin causes a combination of ulcerative, analgesic, and anti-inflammatory effects. Whereas ulcer formation is mediated by the proapoptotic activity of mycolactone on skin cells via hyperactivation of Wiskott-Aldrich syndrome proteins, analgesia results from neuronal hyperpolarization via signaling through angiotensin II type 2 receptors. Mycolactone also blunts the capacity of immune cells to produce inflammatory mediators by an independent mechanism of protein synthesis blockade. In an attempt to isolate the structural determinants of mycolactone's immunosuppressive activity, we screened a library of synthetic subunits of mycolactone for inhibition of cytokine production by activated T cells. The minimal structure retaining immunosuppressive activity was a truncated version of mycolactone, missing one of the two core-branched polyketide chains. This compound inhibited the inflammatory cytokine responses of human primary cells at noncytotoxic doses and bound to angiotensin II type 2 receptors comparably to mycolactone in vitro. Notably, it was considerably less toxic than mycolactone in human primary dermal fibroblasts modeling ulcerative activity. In mouse models of human diseases, it conferred systemic protection against chronic skin inflammation and inflammatory pain, with no apparent side effects. In addition to establishing the anti-inflammatory potency of mycolactone in vivo, our study therefore highlights the translational potential of mycolactone core-derived structures as prospective immunosuppressants.
Asunto(s)
Inflamación/tratamiento farmacológico , Macrólidos/uso terapéutico , Animales , Enfermedad Crónica , Células HeLa , Humanos , Inmunomodulación , Inflamación/patología , Células Jurkat , Macrólidos/química , Ratones , Mycobacterium ulcerans/fisiología , Dolor/complicaciones , Dolor/tratamiento farmacológico , Sustancias Protectoras/uso terapéutico , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
The human body is constantly exposed to the risk of traumatic lesions. ROQUETTE Schizochytrium sp. (SCs) is a marine microalgae containing large amounts of health-valuable nutrients, more particularly polyunsaturated fatty acids such as docosahexaenoic acid. SCs was investigated by oral administration (125, 250 and 500 mg/kg) and cutaneous application (2.5, 5.0 and 10.0%) to evaluate its impact in two dermatological disorder models in mice: skin inflammation and wound healing. For skin inflammation, it was administered during 14 days starting one week before the induction of chronic skin inflammation by repeated cutaneous application of 12-O-tetradecanoylphorbol 13-acetate (TPA). For wound healing the microalgae was administered after incisional wound healing of the skin until complete wound healing. Results indicated that oral and topical administrations of the two higher doses of SCs had significant effects on macroscopic score of skin inflammation. It had also efficient effect on healing process and duration of wound healing with a dose-response by oral administration and a maximal effect observed from the lowest to the highest dose by topical application. These findings suggest that administration of SCs by both oral and topical routes appeared to have beneficial effects on skin lesions.
Asunto(s)
Antiinflamatorios/administración & dosificación , Dermatitis/prevención & control , Microalgas/metabolismo , Piel/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Heridas Penetrantes/tratamiento farmacológico , Administración Cutánea , Administración Oral , Animales , Antiinflamatorios/metabolismo , Dermatitis/patología , Modelos Animales de Enfermedad , Femenino , Ratones Pelados , Piel/patología , Acetato de Tetradecanoilforbol , Factores de Tiempo , Heridas Penetrantes/patologíaRESUMEN
INTRODUCTION: Clenbuterol has been used to alleviate chronic obstructive pulmonary disease and elicit an anabolic response in muscles. The aim of this study was to determine the influence of muscle mass variation on physical capacities in rats. METHODS: The left hindlimbs of Wistar rats were immobilized for 20 days in plantarflexion with a splint and then remobilized for 16 days. The effect of a non-myotoxic dose of clenbuterol during the immobilization period was evaluated. Physical capacities were coordination, free locomotion, grip strength, and bilateral deficit. RESULTS: Immobilization induced a loss of muscle mass, coordination, and strength without any effect on free locomotion. The positive anabolic effect of clenbuterol did not prevent a loss of physical capacities resulting from immobilization. CONCLUSIONS: Muscle mass correlated strongly with coordination and isometric strength in untreated rats. Anabolic effect, fiber phenotype modification, and perturbation in neuromuscular communication with clenbuterol improved muscle mass, but it altered physical capacities.
Asunto(s)
Broncodilatadores/uso terapéutico , Clenbuterol/uso terapéutico , Actividad Motora/fisiología , Atrofia Muscular/tratamiento farmacológico , Atrofia Muscular/rehabilitación , Análisis de Varianza , Animales , Modelos Animales de Enfermedad , Conducta Exploratoria , Locomoción , Masculino , Actividad Motora/efectos de los fármacos , Contracción Muscular/efectos de los fármacos , Contracción Muscular/fisiología , Fuerza Muscular/efectos de los fármacos , Fuerza Muscular/fisiología , Atrofia Muscular/etiología , Unión Neuromuscular/efectos de los fármacos , Unión Neuromuscular/fisiopatología , Desempeño Psicomotor/efectos de los fármacos , Desempeño Psicomotor/fisiología , Ratas , Ratas Wistar , Restricción Física/efectos adversos , Estadística como Asunto , Factores de TiempoRESUMEN
The human body is constantly exposed to the risk of traumatic lesions. Chlorella is a green microalgae enriched with nutrients, vitamins, minerals and chlorophyll. In some communities, Chlorella is a traditional medicinal plant used for the management of inflammation-related diseases. ROQUETTE Chlorella sp. (RCs) was investigated by oral administration (125, 250 and 500 mg/kg) and cutaneous application (2.5, 5.0 and 10.0%) to evaluate its impact in two dermatological disorder models in mice: skin inflammation and wound healing. For skin inflammation, it was administered during 14 days starting one week before the induction of chronic skin inflammation by repeated cutaneous application of 12-Otetradecanoylphorbol 13-acetate (TPA). For wound healing the microalgae was administered by topical application after scarification of the skin until complete wound healing. Results indicated that oral and topical administrations of the two higher doses of RCs had significant effects on macroscopic score of skin inflammation with an efficient effect on microscopic score with cutaneous application. The microalgae had also efficient effect on healing process and duration of wound healing for both administration routes and particularly at the two highest doses of RCs. These findings suggest that administration of RCs by both oral and topical routes appeared to have beneficial effects on skin lesions.
Asunto(s)
Chlorella/química , Inflamación/tratamiento farmacológico , Extractos Vegetales/química , Extractos Vegetales/farmacología , Piel/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Administración Oral , Administración Tópica , Animales , Dermatitis/tratamiento farmacológico , Femenino , RatonesRESUMEN
Consumption of diet rich in lignans may decrease the risk of some chronic hormonal conditions such as benign prostatic hyperplasia (BPH). This study investigated whether a lignan-rich extract from flaxseed hulls, LinumLife EXTRA (LLE), could prevent BPH using the testosterone propionate (TP)-induced BPH rat model. Male Wistar-Unilever rats were randomly divided into four groups of 12 rats each: a negative control group fed with control diet and receiving daily subcutaneous injections of corn oil without TP, and three groups fed with control diet (positive control), diet containing 0.5% LLE (LLE 0.5) or 1.0% LLE (LLE 1.0) and receiving daily subcutaneous injections of TP in corn oil. Treatments with diets started 2 weeks before the induction of BPH and were carried out for 5 consecutive weeks. The influence of TP and LLE on body weight (BW), food and water consumptions, and enterolactone (ENL) levels in serum and urine of rats was examined at the end of the 5-week treatment period. TP significantly diminished the mean body weight gain (MBWG) of positive control rats and their food and water consumptions while LLE reduced significantly this MBWG reduction in a dose-dependent manner. The lignan-rich extract significantly inhibited TP-induced prostate size ratio (prostate weight/rat BW) increase in comparison with positive controls (P<.001). This effect was dose dependent. Higher serum and urine levels of ENL correlated well with the dose of extract provided to rats. It was concluded that the lignan-rich flaxseed hull extract prevented the TP-induced BPH indicating it might be beneficial in the prevention of BPH.
Asunto(s)
Lino/química , Lignanos/uso terapéutico , Fitoterapia , Extractos Vegetales/uso terapéutico , Próstata/efectos de los fármacos , Hiperplasia Prostática/prevención & control , 4-Butirolactona/análogos & derivados , 4-Butirolactona/metabolismo , 4-Butirolactona/farmacología , 4-Butirolactona/uso terapéutico , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Ingestión de Líquidos/efectos de los fármacos , Ingestión de Energía/efectos de los fármacos , Hiperplasia , Lignanos/metabolismo , Lignanos/farmacología , Masculino , Extractos Vegetales/farmacología , Próstata/patología , Hiperplasia Prostática/inducido químicamente , Ratas Wistar , Semillas/química , Propionato de Testosterona , Aumento de Peso/efectos de los fármacosRESUMEN
The increasing prevalence and social burden of subclinical anxiety in the western world represents a significant psychosocial and financial cost. Consumers are favouring a more natural and nonpharmacological approach for alleviating the effects of everyday stress and anxiety. The gamma-aminobutyric acid (GABA) receptor is the primary mediator of central inhibitory neurotransmission, and GABA-receptor agonists are well known to convey anxiolytic effects. Using an in vitro screening approach to identify naturally occurring phytochemical GABA agonists, we discovered the plant secondary metabolite p-coumaric acid to have significant GABAergic activity, an effect that could be blocked by co-administration of the specific GABA-receptor antagonist, picrotoxin. Oral administration of p-coumaric acid to rodents induced a significant anxiolytic effect in vivo as measured using the elevated plus paradigm, in line with the effects of oral diazepam. Given that p-coumaric acid is reasonably well absorbed following oral consumption in man and is relatively nontoxic, it may be suitable for the formulation of a safe and effective anxiolytic functional food.
Asunto(s)
Ansiolíticos/farmacología , Ácidos Cumáricos/farmacología , Antagonistas del GABA/farmacología , Receptores de GABA-A/metabolismo , Animales , Diazepam/farmacología , Masculino , Actividad Motora/efectos de los fármacos , Fitoquímicos/farmacología , Picrotoxina/efectos adversos , Propionatos , Ratas , Ratas Wistar , Transmisión Sináptica/efectos de los fármacosRESUMEN
The orange-peel derived terpene d-Limonene, probably through its metabolite, perillyl alcohol (POH), has been reported to have tissue-repair properties. Two murine models of respectively 12-O-Tetradecanoylphorbol-13-Acetate (TPA)-induced dermatitis and mechanical skin lesion were used here to assess the efficacy of d-Limonene or POH applied topically. Macroscopic and microscopic evaluation of skin lesions was performed as well as that of P-selectin expression, together with measurements of serum concentrations of IL-1ß, IL-6 and TNF-α in the first model. Healing and angiogenesis around the scar were examined in the second model. Because differences in angiogenesis were noted, the effect of both d-Limonene and POH was further tested on an in vitro model of endothelial microtubules formation. Both d-Limonene and POH reduced the severity and extension of TPA-induced skin lesions with significantly lowered macroscopic and microscopic scores (p<0.04 in both cases). Moreover, the expression of P-selectin induced by TPA was abrogated by POH and significantly lower serum concentrations of IL-6 and TNF-α were observed in d-Limonene- and POH-treated mice (p<0.04 and 0.03). In the second model, tissue regeneration was improved, especially by POH, and was clearly associated with reduced neovascularization. This surprising anti-angiogenic effect was confirmed in the matrigel model of endothelial microtubules formation. These studies show that d-Limonene and POH demonstrate significant anti-inflammatory effects in murine dermal inflammation and wound-healing. The decreased systemic cytokine production as well as a consistent inhibition of endothelial P-selectin expression and neo-vascularization induced by these terpenic compounds contribute to their healing effects on the epidermal barrier.
Asunto(s)
Inhibidores de la Angiogénesis/uso terapéutico , Citrus sinensis , Ciclohexenos/uso terapéutico , Dermatitis Irritante/tratamiento farmacológico , Monoterpenos/uso terapéutico , Fitoterapia , Piel/efectos de los fármacos , Terpenos/uso terapéutico , Administración Cutánea , Animales , Células Cultivadas , Citocinas/sangre , Modelos Animales de Enfermedad , Endotelio/efectos de los fármacos , Endotelio/patología , Femenino , Frutas , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Mediadores de Inflamación/sangre , Limoneno , Ratones , Ratones Pelados , Microtúbulos/efectos de los fármacos , Selectina-P/metabolismo , Ésteres del Forbol/administración & dosificación , Piel/lesiones , Piel/patología , Cicatrización de Heridas/efectos de los fármacosRESUMEN
Stress is closely linked by its biological mechanisms to inflammation and by its consequences to accelerated aging. Stress triggers a hormonal response along the hypothalamus-pituitary-adrenal (HPA) axis, which can disrupt the ortho/parasympathetic balance essential for a harmonious life. Proper nutrition, adequate physical activity, and limiting the harmful influence of stress play important roles in avoiding the development of disease and promoting healthy aging. d-Limonene, a monoterpene shown to reduce inflammatory parameters in several pre-clinical and clinical models, could also produce an anti-stress action by altering ortho/parasympathetic parameters as well as central neurotransmitter functions. Here we report on a rat model, where a functional observational battery (FOB) was performed by submitting animals to non-pathological stress. d-Limonene or its metabolite perillyl alcohol (POH) were administered per os at a dose of 10 mg/kg. FOB tests were performed 1 hr before gavage and then at 60, 120, and 180 min. These tests confirmed the stressed status of control rats fed vehicle. Conversely, a series of parameters were significantly less disturbed in treated rats, who retained a better activity and displayed less signs of stress. These effects were more pronounced and sustained after ingestion of d-limonene than POH, suggesting the role of endogeneous metabolization of the terpene. These studies show that d-limonene exerts, through its metabolite POH, a significant anti-stress action measurable by behavioral and physiologic parameters under the influence of the nervous system. In addition to its anti-inflammatory effects, a beneficial role as an anti-stress substance could thus be claimed for d-limonene used as a dietary supplement.
Asunto(s)
Ciclohexenos/farmacología , Monoterpenos/metabolismo , Monoterpenos/farmacología , Estrés Fisiológico/efectos de los fármacos , Terpenos/farmacología , Animales , Conducta Animal/efectos de los fármacos , Conducta Alimentaria/efectos de los fármacos , Femenino , Limoneno , Ratas Wistar , Factores de TiempoRESUMEN
AIMS: To further explore the anti-inflammatory properties of d-Limonene. MAIN METHODS: A rat model was used to compare evolution of TNBS (2,5,6-trinitrobenzene sulfonic acid)-induced colitis after oral feeding with d-Limonene compared to ibuprofen. Peripheral levels of TNF-α (Tumor Necrosis Factor alpha) were assessed in all animals. Cell cultures of fibroblasts and enterocytes were used to test the effect of d-Limonene respectively on TNFα-induced NF-κB (nuclear factor-kappa B) translocation and epithelial resistance. Finally, plasmatic inflammatory markers were examined in an observational study of diet supplementation with d-Limonene-containing orange peel extract (OPE) in humans. KEY FINDINGS: Administered per os at a dose of 10mg/kg p.o., d-Limonene induced a significant reduction of intestinal inflammatory scores, comparable to that induced by ibuprofen. Moreover, d-Limonene-fed rats had significantly lowered serum concentrations of TNF-α compared to untreated TNBS-colitis rats. The anti-inflammatory effect of d-Limonene also involved inhibition of TNFα-induced NF-κB translocation in fibroblast cultures. The application of d-Limonene on colonic HT-29/B6 cell monolayers increased epithelial resistance. Finally, inflammatory markers, especially peripheral IL-6, markedly decreased upon OPE supplementation of elderly healthy subjects submitted or not to 56 days of dietary supplementation with OPE. SIGNIFICANCE: In conclusion, d-Limonene indeed demonstrates significant anti-inflammatory effects both in vivo and in vitro. Protective effects on the epithelial barrier and decreased cytokines are involved, suggesting a beneficial role of d-Limonene as diet supplement in reducing inflammation.